Filing Details

Accession Number:
0001209191-23-044683
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-04 18:54:23
Reporting Period:
2023-08-02
Accepted Time:
2023-08-04 18:54:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1532346 Atreca Inc. BCEL Pharmaceutical Preparations (2834) 273723255
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1934498 E Stephen Gould 835 Industrial Road, Suite 400
San Carlos CA 94070
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-08-02 4,076 $0.95 28,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" and does not represent a discretionary trade by the Reporting Person.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.92 to$0.97 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of theSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within therange set forth in this footnote.